SOURCE: Pharm Control Ltd.

January 30, 2007 09:00 ET

Pharm Control Announces the Acquisition of Licensing Rights in Europe

NEW YORK, NY -- (MARKET WIRE) -- January 30, 2007 -- Pharm Control (PINKSHEETS: PMCL) is proud to announce the acquisition of licenses required to sell its products in Poland and Germany, where natural and homeopathic acceptance of natural solutions is well known.

The first trial shipments of pills have been shipped to Germany and Poland and the Company expects that its Control 24 product will be available on the shelves in both countries by the middle of 2007.

About Pharm Control Ltd.

Pharm Control Ltd. is a leading medicine Research and Development company that is devoted to developing medicines that allow patients to live longer, healthier, and more productive lives. The Company's founders have invested over 10 years of research discovering and developing new and effective non-synthetic medicines to fight disorders and sickness in the modern world.

Safe Harbor Statement

The preceding includes forward-looking statements, which involve known and unknown risks, and uncertainties, which may cause the company's actual results in future periods to differ materially from forecasted results. Any forward-looking statements above are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially due to a variety of factors, including, without limitation, competition, intellectual property rights, litigation, needs of liquidity, and other risks detailed from time to time in the company's reports filed with the SEC. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, but not limited to, continued acceptance of the company's products and services, competition, new products and technological changes, as well as any and all "other risks" associated with business.

Contact Information


    Pharm Control Ltd.
    Eugene Kron
    Vice President
    Email: Email Contact
    Tel: (212) 252-4521